Skip to main content
SpringerLink
Log in

Macroprolactinoma: Diagnosis and Management in a Patient with Infertility

  • Chapter
  • First Online:
Pituitary Tumors

  • 485 Accesses

Abstract

A 31-year-old who had a history of delayed puberty and then developed amenorrhea after stopping birth control pills was found to have a macroprolactinoma. Cabergoline therapy resulted in normalization of prolactin and menstrual periods within 6 months. The adenoma size decreased slowly, and the patient conceived. The dopamine agonist was withdrawn upon conception and restarted postpartum. Visual fields were monitored during the pregnancy which was uneventful. The diagnosis and therapy of hyperprolactinemia in a patient seeking fertility and the peri-partum management of prolactinoma during pregnancy are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Landolt AM. [Prolactin-producing pituitary adenomas as a cause of primary amenorrhea and their neurosurgical treatment]. Dtsch Med Wochenschr. 1983;108(8):298–301.

    Google Scholar 

  2. Ajmal A, Joffe H, Nachtigall LB. Psychotropic-induced hyperprolactinemia: a clinical review. Psychosomatics. 2014;55(1):29–36.

    Google Scholar 

  3. Shin SH, et al. Morphine can stimulate prolactin release independent of a dopaminergic mechanism. Can J Physiol Pharmacol. 1988;66(11):1381–5.

    Article  CAS  PubMed  Google Scholar 

  4. Gold MS, et al. Increase in serum prolactin by exogenous and endogenous opiates: evidence for antidopamine and antipsychotic effects. Am J Psychiatry. 1978;135(11):1415–6.

    Article  CAS  PubMed  Google Scholar 

  5. Glezer A, Bronstein MD. Prolactinomas, cabergoline, and pregnancy. Endocrine. 2014;47(1):64–9.

    Article  CAS  PubMed  Google Scholar 

  6. Melmed S, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–88.

    Article  CAS  PubMed  Google Scholar 

  7. Vilar L, Fleseriu M, Bronstein MD. Challenges and pitfalls in the diagnosis of hyperprolactinemia. Arq Bras Endocrinol Metabol. 2014;58(1):9–22.

    Article  PubMed  Google Scholar 

  8. St-Jean E, Blain F, Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf). 1996;44(3):305–9.

    Article  CAS  Google Scholar 

  9. Moraes AB, et al. Giant prolactinomas: the therapeutic approach. Clin Endocrinol (Oxf). 2013;79(4):447–56.

    Article  CAS  Google Scholar 

  10. Brue T, Castinetti F. The risks of overlooking the diagnosis of secreting pituitary adenomas. Orphanet J Rare Dis. 2016;11(1):135.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Faje A, Nachtigall L. Current treatment options for hyperprolactinemia. Expert Opin Pharmacother. 2013;14(12):1611–25.

    Article  CAS  PubMed  Google Scholar 

  12. Biller BM, et al. Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab. 1996;81(6):2338–43.

    PubMed  CAS  Google Scholar 

  13. Molitch ME, et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 1985;60(4):698–705.

    Article  CAS  PubMed  Google Scholar 

  14. Colao A, et al. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab. 1997;82(11):3574–9.

    Article  CAS  PubMed  Google Scholar 

  15. Webster J, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med. 1994;331(14):904–9.

    Article  CAS  PubMed  Google Scholar 

  16. Donegan D, et al. Surgical outcomes of prolactinomas in recent era: results of a heterogenous group. Endocr Pract. 2017;23(1):37–45.

    Article  PubMed  Google Scholar 

  17. Wilson CB. Surgical management of pituitary tumors. J Clin Endocrinol Metab. 1997;82(8):2381–5.

    Article  CAS  PubMed  Google Scholar 

  18. Pashtan I, Oh KS, Loeffler JS. Radiation therapy in the management of pituitary adenomas. Handb Clin Neurol. 2014;124:317–24.

    Article  PubMed  Google Scholar 

  19. Ono M, et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. J Clin Endocrinol Metab. 2010;95(6):2672–9.

    Article  CAS  PubMed  Google Scholar 

  20. Sarwar KN, et al. The prevalence and natural history of pituitary hemorrhage in prolactinoma. J Clin Endocrinol Metab. 2013;98(6):2362–7.

    Article  CAS  PubMed  Google Scholar 

  21. Watt A, Pobereskin L, Vaidya B. Pituitary apoplexy within a macroprolactinoma. Nat Clin Pract Endocrinol Metab. 2008;4(11):635–41.

    Article  CAS  PubMed  Google Scholar 

  22. Briet C, et al. Pituitary apoplexy. Endocr Rev. 2015;36(6):622–45.

    Article  PubMed  Google Scholar 

  23. Molitch ME. Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. Eur J Endocrinol. 2015;172(5):R205–13.

    Article  CAS  PubMed  Google Scholar 

  24. Maiter D, Delgrange E. Therapy of endocrine disease: the challenges in managing giant prolactinomas. Eur J Endocrinol. 2014;170(6):R213–27.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Souad Enakuaa & Lisa B. Nachtigall

Authors
  1. Souad Enakuaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa B. Nachtigall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisa B. Nachtigall .

Editor information

Editors and Affiliations

  1. Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Lisa B. Nachtigall

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Enakuaa, S., Nachtigall, L.B. (2018). Macroprolactinoma: Diagnosis and Management in a Patient with Infertility. In: Nachtigall, L. (eds) Pituitary Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-90909-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90909-7_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90907-3

  • Online ISBN: 978-3-319-90909-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation